Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amarin Corp Plc (NQ: AMRN)
6.920 USD  +0.030 (+0.44%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Amarin Corp Plc
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
38 39 Next >
Amarin Down 17.8% Since SmarTrend Downtrend Call (AMRN)
December 24, 2012
from Comtex SmarTrend® News Briefs
The Straight Truth, Investing in AAPL, MCP, AMRN and SD
December 21, 2012
from Marketwired News Releases
Merck's (MRK) Tredaptive Miss May Benefit Amarin (AMRN) - Analyst
December 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7963955 for the full story. Read More
from StreetInsider.com News Articles
Streetinsider.com's Hot Lunchtime Reads 12/20: (AMRN) (DKS) (ZNGA) (BAC) (AAPL)
December 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7963607 for the full story. Read More
from StreetInsider.com News Articles
Canaccord Genuity Cuts PT on Amarin (AMRN) But Still Sees a Double
December 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7963352 for the full story. Read More
from StreetInsider.com News Articles
Strategy Behind Our Success, We Get in Early: AAPL, MCP, AMRN and SD
December 20, 2012
from Marketwired News Releases
The Reason It Trades, What's Moving SWHC, PFE, AMRN and LFVN
December 19, 2012
from Marketwired News Releases
Amarin Corp (AMRN) Submits sNDA for New Vascepa API Supplier
December 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7959052 for the full story. Read More
from StreetInsider.com News Articles
Amarin Announces Submission of Supplemental New Drug Application for Chemport, Inc. as an Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
December 19, 2012
from GlobeNewswire News Releases
Amarin (AMRN) Sees Late-Day Volatility
December 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7957035 for the full story. Read More
from StreetInsider.com News Articles
The Real Story Behind PFE, LFVN, AMRN and HOV
December 18, 2012
from Marketwired News Releases
VFC's Stock House Weekly Stock Watch, Week of 17 December
December 18, 2012
from EmailWire.Com Press Releases
Following Fifth NCE Delay, Amarin (AMRN) Has to Go-It-Alone on Vascepa - MKM
December 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7952928 for the full story. Read More
from StreetInsider.com News Articles
Perfect Trade Setups, How to Play MDBX, STSI, ZGNX and AMRN
December 17, 2012
from Marketwired News Releases
Amarin Completes Dosing in a Fixed-Dose Combination Study With Vascepa and a Leading Statin
December 17, 2012
Amarin Corporation (NASDAQ: AMRN ) announced today that it has completed dosing and pharmacokinetic sampling in a study to test a fixed-dose combination of Vascepa® (icosapent ethyl) capsules and a... Read More
category Contracts , Management , Benzinga , and 6 more.
from Latest Articles from Benzinga.com
Amarin (AMRN) Completes Vascepa Pharmacokinetic Sampling Study
December 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7951692 for the full story. Read More
from StreetInsider.com News Articles
Amarin Closes Dosing in Fixed-Dose Combination Study with Vascepa
December 17, 2012
Amarin Corporation plc (Nasdaq: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that it has... Read More
category Benzinga , AMRN , News , and 2 more.
from Latest Articles from Benzinga.com
Amarin Announces Completion of Dosing in a Fixed-Dose Combination Study With Vascepa(R) and a Leading Statin
December 17, 2012
from GlobeNewswire News Releases
FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg
December 14, 2012
View Orange Book .(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Read More
category Benzinga , AMRN , News , and 2 more.
from Latest Articles from Benzinga.com
Amarin (AMRN) Slips as FDA Updates Orange Book
December 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7949951 for the full story. Read More
from StreetInsider.com News Articles
Small Stocks to Watch: DCT, CIEN, AMRN, ZQK, EGHT
December 14, 2012
Houston, TX -- (SBWIRE) -- 12/14/2012 -- DCT Industrial Trust Inc. (NYSE:DCT) is currently trading at $6.34, 0.63% higher. DCT Industrial Trust Inc. (DCT) is an industrial real estate company that... Read More
from SBWire - Latest Press Releases
Amarin (AMRN) in Focus as Traders Await NCE Decision on Vascepa
December 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7949762 for the full story. Read More
from StreetInsider.com News Articles
Perfect Trade Setups, How to Play AAPL, MCP, AMRN and SD
December 14, 2012
from Marketwired News Releases
Options Players Wage on Amarin Corporation (AMRN)
December 14, 2012
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ... Read More
from AVAFIN
Benzinga's Top Pre-Market Gainers
December 13, 2012
Best Buy Co (NYSE: BBY ) soared 12.07% to $13.65 in the pre-market trading. Best Buy's founder Richard Schulze is likely to make a fully-financed offer to acquire the company, according to the... Read More
category S , US18538Q1058 , PHMD , and 13 more.
from Latest Articles from Benzinga.com
Amarin Receives Patent Allowance for Application 13/623,450 Related to Vascepa(R)
December 13, 2012
Amarin Corporation plc (Nasdaq: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the United... Read More
category Benzinga , AMRN , News , and 2 more.
from Latest Articles from Benzinga.com
Amarin (AMRN) Receives Notice of Allowance for '450 Patent
December 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7945393 for the full story. Read More
from StreetInsider.com News Articles
Amarin Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa(R) and FDA Approved MARINE Indication
December 13, 2012
Strengthens Positioning of Vascepa for Exclusivity Into 2030 Read More
from GlobeNewswire News Releases
Strategy Behind Our Success, We Get in Early: AMRN, VRX, TEVA and PFE
December 12, 2012
from Marketwired News Releases
Amarin Announces David Stack Appointed to Board of Directors
December 12, 2012
Amarin Corporation (NASDAQ: AMRN ) today announced that David Stack, President and Chief Executive Officer of Pacira Pharmaceuticals, has joined Amarin's Board of Directors as an independent director... Read More
category Earnings , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
38 39 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here